Regenxbio Inc (RGNX)
Statistics
Key valuation multiples, financial performance ratios, profitability metrics, and per share data consolidated into a single structured view. Each metric is benchmarked against both industry and sector averages — providing immediate context on whether the company is trading at a premium or discount relative to its direct peers and the broader market segment.
Valuation & Market Metrics
Market Capitalization
$0.53B
EV to revenue ratio (TTM)
2.08
EV to ebitda
-3.37
Financial Performance
Revenue (TTM)
$0.15B
Gross profit (TTM)
-$0.10B
EBITDA
-$0.17B
Profitability
Operating margin (TTM)
-803.00%
Profit margin
-113.90%
Return on assets (TTM)
-23.40%
Return on equity (TTM)
-113.20%
Per Share Metrics
Revenue per share (TTM)
$2.77
EPS
-$3.20
Diluted EPS (TTM)
-$3.20
Book value
$2.24
Dividend per share
n/a
Dividend yield
n/a
Valuation Multiples
P/E ratio
n/a
Trailing P/E
n/a
Forward P/E
n/a
PEG ratio
0.26
Price to sales ratio (TTM)
3.47
Price to book ratio (TTM)
3.41
Growth
Quarterly earnings growth (YoY)
-69.20%
Quarterly revenue growth (YoY)
<0.01%
Analyst Sentiment
Strong buy
3
Buy
7
Hold
1
Sell
0
Strong sell
0
Risk & Volatility
Beta
1.23